Robert Lechleider - Nov 21, 2024 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Medical Officer
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
Nov 21, 2024
Transactions value $
$149,800
Form type
4
Date filed
11/25/2024, 08:35 AM
Previous filing
Aug 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $150K +15.8K $9.48 15.8K Nov 21, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price for the reported transactions was $9.478. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, the Reporting Person will provide the full information regarding the securities purchased.